CA2466082A1 - Anti-microbial composition comprising a metal ion chelating agent - Google Patents

Anti-microbial composition comprising a metal ion chelating agent Download PDF

Info

Publication number
CA2466082A1
CA2466082A1 CA002466082A CA2466082A CA2466082A1 CA 2466082 A1 CA2466082 A1 CA 2466082A1 CA 002466082 A CA002466082 A CA 002466082A CA 2466082 A CA2466082 A CA 2466082A CA 2466082 A1 CA2466082 A1 CA 2466082A1
Authority
CA
Canada
Prior art keywords
metal ion
ion chelating
chelating agent
composition according
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002466082A
Other languages
English (en)
French (fr)
Inventor
Alan Edwin Jemmett
Jack Schofield
Russell Taylor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AQand PLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0124527A external-priority patent/GB0124527D0/en
Priority claimed from GB0217954A external-priority patent/GB0217954D0/en
Application filed by Individual filed Critical Individual
Publication of CA2466082A1 publication Critical patent/CA2466082A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/473Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4738Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/51Chelating agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002466082A 2001-10-12 2002-10-14 Anti-microbial composition comprising a metal ion chelating agent Abandoned CA2466082A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0124527A GB0124527D0 (en) 2001-10-12 2001-10-12 The destruction of micro-organisms by the use of chelating substances to render metal ions inaccessible to the organisms
GB0124527.3 2001-10-12
GB0217954A GB0217954D0 (en) 2002-08-02 2002-08-02 Anti-microbial composition
GB0217954.7 2002-08-02
PCT/GB2002/004662 WO2003032944A1 (en) 2001-10-12 2002-10-14 Anti-microbial composition comprising a metal ion chelating agent

Publications (1)

Publication Number Publication Date
CA2466082A1 true CA2466082A1 (en) 2003-04-24

Family

ID=26246646

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002466082A Abandoned CA2466082A1 (en) 2001-10-12 2002-10-14 Anti-microbial composition comprising a metal ion chelating agent

Country Status (8)

Country Link
US (2) US20040248874A1 (enExample)
EP (1) EP1474101A1 (enExample)
JP (1) JP2005511529A (enExample)
KR (1) KR20040062561A (enExample)
CN (1) CN100384422C (enExample)
CA (1) CA2466082A1 (enExample)
MX (1) MXPA04003408A (enExample)
WO (1) WO2003032944A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0409725D0 (en) * 2004-05-04 2004-06-09 Taylor Russell The method of manufacture and application of a chelating substance for the purpose of altering and changing the conditions in female reproductive organs
US20080039508A1 (en) * 2004-07-15 2008-02-14 Aq+Plc Treatment Of Tumours
GB0415985D0 (en) * 2004-07-19 2004-08-18 Taylor Russell Methods of manufacture and applications of a chelating compounds or substances that when used as a treatment for burns will assist in the growth
GB0507490D0 (en) * 2005-04-14 2005-05-18 Aq & Plc Treatment of animal parasites
WO2008025755A1 (de) * 2006-09-01 2008-03-06 Basf Se Verwendung von n-haltigen heterozyklen in dermokosmetika
JP4974709B2 (ja) * 2007-02-28 2012-07-11 日油株式会社 皮膚化粧料
US7928111B2 (en) * 2007-06-08 2011-04-19 Senomyx, Inc. Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors
UA113831C2 (xx) 2008-07-31 2017-03-27 Способи і проміжні сполуки для одержання підсилювачів солодкого смаку
EP3814344B1 (en) 2018-08-07 2024-07-24 Firmenich Incorporated 5-substituted 4-amino-1h-benzo[c][1,2,6]thiadiazine 2,2-dioxides and formulations and uses thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH236185A (fr) * 1941-04-12 1945-01-31 Kolb Emile Procédé pour prévenir ou combattre les maladies cryptogamiques des végétaux.
US3873703A (en) * 1970-02-13 1975-03-25 Ciba Geigy Ag Bactericidal and fungicidal compositions and methods of killing bacteria and fungi using 8-oxyguinoline-and 8-oxyguinaldine acrylates
US4199602A (en) * 1978-02-23 1980-04-22 Economics Laboratory, Inc. Control of mastitis and compositions therefor
CA1163561A (en) * 1979-11-06 1984-03-13 Cyril Boroda Preparation containing nitroglycerine and optionally other medicaments and preparation thereof
US4448889A (en) * 1982-06-18 1984-05-15 Instrumentation Laboratory Inc. Fluid analysis
FR2729764B1 (fr) * 1986-09-16 1997-04-11 Thomson Csf Radar a champ angulaire instantane important et haut pouvoir instantane de resolution angulaire, notamment pour autodirecteur de missile
FR2614788B1 (fr) * 1987-05-04 1989-07-28 Richard Marcel Composition pharmaceutique a activite antiseptique
US5057435A (en) * 1990-10-12 1991-10-15 Synermed, Inc. Reagent and methods for calcium determination
GB9313866D0 (en) * 1993-07-05 1993-08-18 Diomed Dev Ltd Compositions for the treatment of inflammatory proliferative skin disease and their use
GB2279567B (en) * 1993-07-05 1997-04-02 Diomed Dev Ltd Compositions for the treatment of inflammatory proliferative skin disease and their use
GB9319104D0 (en) * 1993-09-15 1993-11-03 Unilever Plc Skin care method & composition
FR2711526B1 (fr) * 1993-10-22 1996-01-19 Richard Laboratoire M Utilisation de l'Acriflavine comme agent anti herpès et anti zona.
JP2000016904A (ja) * 1998-07-01 2000-01-18 Tokuriki Kagaku Kenkyusho:Kk 抗菌抗かび剤および抗菌抗かび材料

Also Published As

Publication number Publication date
US20040248874A1 (en) 2004-12-09
MXPA04003408A (es) 2005-08-26
US20060199791A1 (en) 2006-09-07
CN100384422C (zh) 2008-04-30
CN1568177A (zh) 2005-01-19
KR20040062561A (ko) 2004-07-07
WO2003032944A1 (en) 2003-04-24
JP2005511529A (ja) 2005-04-28
EP1474101A1 (en) 2004-11-10

Similar Documents

Publication Publication Date Title
US11103471B2 (en) Antimicrobials and methods of use thereof
ES2882518T3 (es) Composición que comprende proteasa, amilasa y lipasa
AU2005237546B2 (en) Therapeutic antimicrobial compositions and methods
US8193244B1 (en) Antimicrobial agents
US20080057136A1 (en) Disinfecting Composition and Methods of Making and Using Same
EP2320724A2 (en) Sanitising compositions and methods
US20040191274A1 (en) Topical composition
JP2019104757A (ja) 細菌性バイオフィルムを除去するためのセアプローゼの使用
US20100120915A1 (en) Antimicrobials and related methods
US20120270935A1 (en) Formulations
US20040248874A1 (en) Anti-microbial composition comprising a metal ion chelating agent
US4717737A (en) Anti-bacterial methods and agent
US20100291168A1 (en) Antimicrobial formulations comprising a combination of a pyridine thiol and a bis-quinolinium salt
US4752617A (en) Anti-bacterial methods and agents
ES2202872T3 (es) Composicion protectora de la piel.
AU2002330650A1 (en) Anti-microbial composition comprising a metal ion chelating agent
IL172731A (en) Barrier formulation comprising a silicone based emulsion
CN110652464A (zh) 抗菌洗涤剂及其制备方法
JPH0536404B2 (enExample)
AU2006235798B2 (en) Topical composition
JPH11199476A (ja) 消毒及び/又は殺菌用組成物
ZA200604768B (en) Disinfecting composition and methods of making and using same

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued